STAAR Surgical Company (STAA)
STAA Stock Price Chart
Explore STAAR Surgical Company interactive price chart. Choose custom timeframes to analyze STAA price movements and trends.
STAA Company Profile
Discover essential business fundamentals and corporate details for STAAR Surgical Company (STAA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
24 Feb 1992
Employees
1.16k
Website
https://www.staar.comCEO
Warren Foust
Description
STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated injector systems, crucial for cataract surgery. The company also sells various injector components and ancillary medical instruments and devices. Its market outreach extends to a diverse array of healthcare providers, such as ophthalmic surgeons, specialized vision and surgical centers, hospitals, governmental healthcare facilities, and distributors. These products are predominantly utilized by ophthalmologists. Sales are conducted directly via its own sales force in key countries like the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. In other significant markets, including China, Korea, India, France, the Benelux region, Italy, and other international territories, the company employs a hybrid sales model, leveraging both its direct representatives and independent distributors. Founded in 1982, STAAR Surgical Company is headquartered in Lake Forest, California.
STAA Financial Timeline
Browse a chronological timeline of STAAR Surgical Company corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is $0.21, while revenue estimate is $90.57m.
Earnings released on 13 May 2026
EPS came in at $0.38 surpassing the estimated $0.05 by +600.85%, while revenue for the quarter reached $93.52m , beating expectations by +18.81%.
Earnings released on 3 Mar 2026
EPS came in at -$0.20 falling short of the estimated $0.18 by -211.11%, while revenue for the quarter reached $57.80m , missing expectations by -22.89%.
Earnings released on 5 Nov 2025
EPS came in at $0.46 surpassing the estimated $0.18 by +155.56%, while revenue for the quarter reached $94.73m , beating expectations by +25.40%.
Earnings released on 6 Aug 2025
EPS came in at -$0.07 surpassing the estimated -$0.56 by +87.50%, while revenue for the quarter reached $44.32m , missing expectations by -50.29%.
Earnings released on 7 May 2025
EPS came in at -$0.52 surpassing the estimated -$0.59 by +11.86%, while revenue for the quarter reached $42.59m , beating expectations by +5.68%.
Earnings released on 11 Feb 2025
EPS came in at -$0.50 falling short of the estimated $0.02 by -2.60k%, while revenue for the quarter reached $48.95m , missing expectations by -36.82%.
Earnings released on 30 Oct 2024
EPS came in at $0.37 surpassing the estimated $0.19 by +94.74%, while revenue for the quarter reached $88.59m , beating expectations by +13.82%.
Earnings released on 7 Aug 2024
EPS came in at $0.33 surpassing the estimated $0.25 by +32.00%, while revenue for the quarter reached $99.01m , beating expectations by +4.00%.
Earnings released on 7 May 2024
EPS came in at $0.06 surpassing the estimated $0.05 by +20.00%, while revenue for the quarter reached $77.36m , beating expectations by +3.27%.
Earnings released on 26 Feb 2024
EPS came in at $0.24 surpassing the estimated $0.19 by +26.32%, while revenue for the quarter reached $76.27m , beating expectations by +0.50%.
Earnings released on 1 Nov 2023
EPS came in at $0.30 surpassing the estimated $0.20 by +50.00%, while revenue for the quarter reached $80.31m , missing expectations by -0.01%.
Earnings released on 2 Aug 2023
EPS came in at $0.40 surpassing the estimated $0.32 by +25.00%, while revenue for the quarter reached $92.31m , missing expectations by -0.22%.
Earnings released on 3 May 2023
EPS came in at $0.18 surpassing the estimated $0.11 by +63.64%, while revenue for the quarter reached $73.53m , beating expectations by +9.81%.
Earnings released on 21 Feb 2023
EPS came in at $0.12 surpassing the estimated $0.05 by +140.00%, while revenue for the quarter reached $64.04m , missing expectations by -0.12%.
Earnings released on 2 Nov 2022
EPS came in at $0.37 surpassing the estimated $0.21 by +76.19%, while revenue for the quarter reached $76.05m , beating expectations by +1.46%.
Earnings released on 10 Aug 2022
EPS came in at $0.42 surpassing the estimated $0.25 by +68.00%, while revenue for the quarter reached $81.10m , beating expectations by +1.23%.
Earnings released on 4 May 2022
EPS came in at $0.29 surpassing the estimated $0.16 by +81.25%, while revenue for the quarter reached $63.20m , beating expectations by +4.41%.
Earnings released on 23 Feb 2022
EPS came in at $0.19 surpassing the estimated $0.16 by +18.75%, while revenue for the quarter reached $59.00m , missing expectations by -0.82%.
Earnings released on 3 Nov 2021
EPS came in at $0.21 surpassing the estimated $0.16 by +31.25%, while revenue for the quarter reached $58.35m , beating expectations by +22.22%.
Earnings released on 4 Aug 2021
EPS came in at $0.27 surpassing the estimated $0.08 by +237.50%, while revenue for the quarter reached $62.37m , beating expectations by +18.73%.
STAA Stock Performance
Access detailed STAA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
